系统性硬化症合并与不合并肺动脉高压患者三步运动后呼气末二氧化碳变化比较
该横断面研究纳入27例在入组前24个月内接受右心导管检查的局限性或弥漫性系统性硬化症患者,比较合并与不合并肺动脉高压者的三步运动试验中呼气末二氧化碳变化及二氧化碳通气当量。结果显示合并肺动脉高压者呼气末二氧化碳变化中位数显著更低、二氧化碳通气当量中位数显著更高,而自我报告问卷和生物标志物无显著差异。
要点
- 系统性硬化症合并肺动脉高压患者三步运动后呼气末二氧化碳变化中位数显著低于不合并者。
- 合并肺动脉高压者二氧化碳通气当量中位数显著高于不合并者。
- 自我报告问卷和生物标志物在两组间无统计学显著差异。
核心结论
- 三步运动试验测得的呼气末二氧化碳变化和二氧化碳通气当量在系统性硬化症合并与不合并肺动脉高压患者间存在统计学显著差异。
- 呼气末二氧化碳变化和二氧化碳通气当量可能作为系统性硬化症人群肺动脉高压的筛查工具。
研究设计与样本
- 横断面研究,纳入27例局限性或弥漫性系统性硬化症患者,均在研究入组前24个月内接受右心导管检查。
- 研究访视包括问卷填写、病史采集、体格检查、三步运动试验和采血。
主要发现
- 合并肺动脉高压的系统性硬化症患者呼气末二氧化碳变化中位数(四分位距)为-2.1(-5.1至0.7)mmHg,不合并者为1.2(-0.7至5.4)mmHg,P=0.035。
- 合并肺动脉高压者二氧化碳通气当量中位数(四分位距)为53.4(39至64.1),不合并者为36.4(31.9至41.1),P=0.035。
- 两组间自我报告数据和生物标志物无统计学显著差异。
临床怎么用
- 在系统性硬化症患者中,可考虑使用三步运动试验测得的呼气末二氧化碳变化和二氧化碳通气当量辅助筛查肺动脉高压。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Pulmonary hypertension (PH) is an important cause of morbidity and mortality in patients with SSc. The submaximal heart and pulmonary evaluation (step test) is a non-invasive, submaximal stress test that could be used to identify SSc patients with PH. Our aims were to determine whether change in end tidal carbon dioxide ([Formula: see text]) from rest to end-exercise, and the minute ventilation to carbon dioxide production ratio ([Formula: see text]), both as measured by the step test, differ between SSc patients with and without PH. We also examined differences in validated self-report questionnaires and potential PH biomarkers between SSc patients with and without PH. METHODS: We performed a cross-sectional study of 27 patients with limited or dcSSc who underwent a right heart catheterization within 24 months prior to study entry. The study visit consisted of questionnaire completion; history; physical examination; step test performance; and phlebotomy. [Formula: see text], [Formula: see text], self-report data and biomarkers were compared between patients with and without PH. RESULTS: SSc patients with PH had a statistically significantly lower median (interquartile range) [Formula: see text] than SSc patients without PH [-2.1 (-5.1 to 0.7) vs 1.2 (-0.7 to 5.4) mmHg, P = 0.035], and a statistically significantly higher median (interquartile range) [Formula: see text] [53.4 (39-64.1) vs 36.4 (31.9-41.1), P = 0.035]. There were no statistically significant differences in self-report data or biomarkers between groups. CONCLUSION: [Formula: see text] and [Formula: see text] as measured by the step test are statistically significantly different between SSc patients with and without PH. [Formula: see text] and [Formula: see text] may be useful screening tools for PH in the SSc population.
引用
- Bernstein EJ, Gordon JK, Spiera RF, et al. Comparison of change in end tidal carbon dioxide after three minutes of step exercise between systemic sclerosis patients with and without pulmonary hypertension. Rheumatology (Oxford). 2016. PMID: 28028158. doi:10.1093/rheumatology/kew365
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。